Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Looking for good code examples for LeetCode problems? You’re in luck! Lots of people share their solutions online, especially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results